These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
349 related articles for article (PubMed ID: 11862330)
1. Effect of repeated treatment with high doses of selegiline on behaviour, striatal dopaminergic transmission and tyrosine hydroxylase mRNA levels. Themann C; Alvarez Fischer D; Gross S; Westermann R; Weihe E; Kuschinsky K; Schäfer H; Ferger B Naunyn Schmiedebergs Arch Pharmacol; 2002 Jan; 365(1):22-8. PubMed ID: 11862330 [TBL] [Abstract][Full Text] [Related]
2. Chronic selegiline administration transiently decreases tyrosine hydroxylase activity and mRNA in the rat nigrostriatal pathway. Vrana SL; Azzaro AJ; Vrana KE Mol Pharmacol; 1992 May; 41(5):839-44. PubMed ID: 1350320 [TBL] [Abstract][Full Text] [Related]
3. The influence of acute and chronic administration of 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline on the function of the nigrostriatal dopaminergic system in rats. Lorenc-Koci E; Antkiewicz-Michaluk L; Kamińska A; Lenda T; Zieba B; Wierońska J; Smiałowska M; Schulze G; Rommelspacher H Neuroscience; 2008 Oct; 156(4):973-86. PubMed ID: 18809471 [TBL] [Abstract][Full Text] [Related]
4. Differentially altered mGluR1 and mGluR5 mRNA expression in rat caudate nucleus and nucleus accumbens in the development and expression of behavioral sensitization to repeated amphetamine administration. Mao L; Wang JQ Synapse; 2001 Sep; 41(3):230-40. PubMed ID: 11418936 [TBL] [Abstract][Full Text] [Related]
5. Time course of tyrosine hydroxylase expression after behavioral sensitization to cocaine. Sorg BA; Chen SY; Kalivas PW J Pharmacol Exp Ther; 1993 Jul; 266(1):424-30. PubMed ID: 8101222 [TBL] [Abstract][Full Text] [Related]
6. Oestrogens prevent loss of dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) in substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice. Jourdain S; Morissette M; Morin N; Di Paolo T J Neuroendocrinol; 2005 Aug; 17(8):509-17. PubMed ID: 16011487 [TBL] [Abstract][Full Text] [Related]
7. Sparing of behavior and basal extracellular dopamine after 6-hydroxydopamine lesions of the nigrostriatal pathway in rats exposed to a prelesion sensitizing regimen of amphetamine. Moroz IA; Peciña S; Schallert T; Stewart J Exp Neurol; 2004 Sep; 189(1):78-93. PubMed ID: 15296838 [TBL] [Abstract][Full Text] [Related]
8. Behavioral motor recovery in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned squirrel monkey (Saimiri sciureus): changes in striatal dopamine and expression of tyrosine hydroxylase and dopamine transporter proteins. Petzinger GM; Fisher B; Hogg E; Abernathy A; Arevalo P; Nixon K; Jakowec MW J Neurosci Res; 2006 Feb; 83(2):332-47. PubMed ID: 16385585 [TBL] [Abstract][Full Text] [Related]
9. Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline. Kupsch A; Sautter J; Götz ME; Breithaupt W; Schwarz J; Youdim MB; Riederer P; Gerlach M; Oertel WH J Neural Transm (Vienna); 2001; 108(8-9):985-1009. PubMed ID: 11716151 [TBL] [Abstract][Full Text] [Related]
10. Effect of AdGDNF on dopaminergic neurotransmission in the striatum of 6-OHDA-treated rats. Smith AD; Kozlowski DA; Bohn MC; Zigmond MJ Exp Neurol; 2005 Jun; 193(2):420-6. PubMed ID: 15869944 [TBL] [Abstract][Full Text] [Related]
11. Dopamine transporter, but not tyrosine hydroxylase, may be implicated in determining individual differences in behavioral sensitization to amphetamine. Dietz DM; Tapocik J; Gaval-Cruz M; Kabbaj M Physiol Behav; 2005 Oct; 86(3):347-55. PubMed ID: 16126238 [TBL] [Abstract][Full Text] [Related]
12. Effects of haloperidol and melatonin on the in situ activity of nigrostriatal tyrosine hydroxylase in male Syrian hamsters. Vriend J; Dreger L Life Sci; 2006 Mar; 78(15):1707-12. PubMed ID: 16263138 [TBL] [Abstract][Full Text] [Related]
13. Different responsiveness of striatonigral and striatopallidal neurons to L-DOPA after a subchronic intermittent L-DOPA treatment. Carta AR; Tronci E; Pinna A; Morelli M Eur J Neurosci; 2005 Mar; 21(5):1196-204. PubMed ID: 15813929 [TBL] [Abstract][Full Text] [Related]
14. Agmatine inhibits morphine-induced locomotion sensitization and morphine-induced changes in striatal dopamine and metabolites in rats. Wei XL; Su RB; Wu N; Lu XQ; Zheng JQ; Li J Eur Neuropsychopharmacol; 2007 Dec; 17(12):790-9. PubMed ID: 17604969 [TBL] [Abstract][Full Text] [Related]
15. Acupuncture attenuates cocaine-induced expression of behavioral sensitization in rats: possible involvement of the dopaminergic system in the ventral tegmental area. Lee B; Han SM; Shim I Neurosci Lett; 2009 Jan; 449(2):128-32. PubMed ID: 18992788 [TBL] [Abstract][Full Text] [Related]
16. Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences. Ahmad M; Saleem S; Ahmad AS; Yousuf S; Ansari MA; Khan MB; Ishrat T; Chaturvedi RK; Agrawal AK; Islam F J Neurochem; 2005 Apr; 93(1):94-104. PubMed ID: 15773909 [TBL] [Abstract][Full Text] [Related]
17. Long-term effects of amphetamine neurotoxicity on tyrosine hydroxylase mRNA and protein in aged rats. Bowyer JF; Frame LT; Clausing P; Nagamoto-Combs K; Osterhout CA; Sterling CR; Tank AW J Pharmacol Exp Ther; 1998 Aug; 286(2):1074-85. PubMed ID: 9694971 [TBL] [Abstract][Full Text] [Related]
18. Repeated exposure to the herbicide atrazine alters locomotor activity and the nigrostriatal dopaminergic system of the albino rat. Rodríguez VM; Limón-Pacheco JH; Mendoza-Trejo MS; González-Gallardo A; Hernández-Plata I; Giordano M Neurotoxicology; 2013 Jan; 34():82-94. PubMed ID: 23123945 [TBL] [Abstract][Full Text] [Related]
19. Differential expression of striatal synaptotagmin mRNA isoforms in hemiparkinsonian rats. Glavan G; Zivin M Neuroscience; 2005; 135(2):545-54. PubMed ID: 16111820 [TBL] [Abstract][Full Text] [Related]
20. Repeated exposure of adult rats to Aroclor 1254 causes brain region-specific changes in intracellular Ca2+ buffering and protein kinase C activity in the absence of changes in tyrosine hydroxylase. Kodavanti PR; Derr-Yellin EC; Mundy WR; Shafer TJ; Herr DW; Barone S; Choksi NY; MacPhail RC; Tilson HA Toxicol Appl Pharmacol; 1998 Dec; 153(2):186-98. PubMed ID: 9878590 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]